Takeda doses first subject in Japanese Covid-19 vaccine trial
Takeda Pharmaceutical has dosed the first subject in its Phase I/II study of Novavax’s Covid-19...
Takeda Pharmaceutical has dosed the first subject in its Phase I/II study of Novavax’s Covid-19...
Speciality pharmaceutical company Kyowa Kirin has reported that the Phase II study of an investigational...
Moderna has dosed the first participant in the Phase I/II study of its Covid-19 vaccine...
The SanBio Group has published the interim analysis data from its Phase II clinical STEM...
Japanese company Shionogi has commenced Phase I/II clinical trial of a prophylactic Covid-19 vaccine candidate...
Clinical-stage biopharma firm Senhwa Biosciences has enrolled the first patient in a Phase II investigator-initiated...
Leading COVID-19 vaccine candidates from Pfizer/BioNTech (BNT-162b2) and Moderna (mRNA-1273) currently in Phase III trials...
Takeda has announced final positive results from the Phase III HELP (Hereditary Angioedema Long-term Prophylaxis)...
Japan’s contract research organisation (CRO) CMIC has employed SUSMED’s trial management system to launch its...
Daiichi Sankyo has dosed the first patient in a first-in-human global Phase I trial to...